Predicting the Risk of Ischemic Stroke in Patients with Atrial Fibrillation using Heterogeneous Drug-protein-disease Network-based Deep Learning

Fuente: arXiv
Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Lyu, Zhiheng, Yang, Jiannan, Xu, Zhongzhi, Wang, Weilan, Cheng, Weibin, Tsui, Kwok-Leung, Tse, Gary, Zhang, Qingpeng
Format: Preprint
Veröffentlicht: 2024
Schlagworte:
Online-Zugang:
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
_version_ 1866929473579909120
author Lyu, Zhiheng
Yang, Jiannan
Xu, Zhongzhi
Wang, Weilan
Cheng, Weibin
Tsui, Kwok-Leung
Tse, Gary
Zhang, Qingpeng
author_facet Lyu, Zhiheng
Yang, Jiannan
Xu, Zhongzhi
Wang, Weilan
Cheng, Weibin
Tsui, Kwok-Leung
Tse, Gary
Zhang, Qingpeng
contents We develop a deep learning model, ABioSPATH, to predict the one-year risk of ischemic stroke (IS) in atrial fibrillation (AF) patients. The model integrates drug-protein-disease pathways and real-world clinical data of AF patients to generate the IS risk and potential pathways for each patient. The model uses a multilayer network to identify the mechanism of drug action and disease comorbidity propagation pathways. The model is tested on the Electronic Health Record (EHR) data of 7859 AF patients from 43 hospitals in Hong Kong. The model outperforms all baselines across all metrics and provides valuable molecular-level insights for clinical use. The model also highlights key proteins in common pathways and potential IS risks tied to less-studied drugs. The model only requires routinely collected data, without requiring expensive biomarkers to be tested.
format Preprint
id arxiv_https___arxiv_org_abs_2403_07475
institution arXiv
publishDate 2024
record_format arxiv
spellingShingle Predicting the Risk of Ischemic Stroke in Patients with Atrial Fibrillation using Heterogeneous Drug-protein-disease Network-based Deep Learning
Lyu, Zhiheng
Yang, Jiannan
Xu, Zhongzhi
Wang, Weilan
Cheng, Weibin
Tsui, Kwok-Leung
Tse, Gary
Zhang, Qingpeng
Quantitative Methods
We develop a deep learning model, ABioSPATH, to predict the one-year risk of ischemic stroke (IS) in atrial fibrillation (AF) patients. The model integrates drug-protein-disease pathways and real-world clinical data of AF patients to generate the IS risk and potential pathways for each patient. The model uses a multilayer network to identify the mechanism of drug action and disease comorbidity propagation pathways. The model is tested on the Electronic Health Record (EHR) data of 7859 AF patients from 43 hospitals in Hong Kong. The model outperforms all baselines across all metrics and provides valuable molecular-level insights for clinical use. The model also highlights key proteins in common pathways and potential IS risks tied to less-studied drugs. The model only requires routinely collected data, without requiring expensive biomarkers to be tested.
title Predicting the Risk of Ischemic Stroke in Patients with Atrial Fibrillation using Heterogeneous Drug-protein-disease Network-based Deep Learning
topic Quantitative Methods
url https://arxiv.org/abs/2403.07475